SRPX2 and skin basal cell carcinoma: As indicated by the amplification profiles of the expected 178 bp long PCR product, in contrast to BCC and SCC (Figure 5A), melanoma samples proved to lack detectable levels of SRPX2 regular gene expression (Figure 5B).